Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.57 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.57 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.52 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5341486 | 0.91 | KDM1A (0.70) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL345223 | 0.86 | SLCO2B1 (0.66) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL4309045 | 0.82 | CYP1A1 (0.56) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL24527515 | 0.79 | KDM1A (0.79) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL4219129 | 0.79 | CYP19A1 (0.57) | CYP19A1 | |
| SCHEMBL3643156 | 0.78 | KDM1A (0.73) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL243404 | 0.76 | DPP4 (0.84) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL30291873 | 0.76 | DPP4 (0.84) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL15080627 | 0.75 | KDM1A (0.85) | KDM1ASLCO2B1SYNJ2DPP4POLB | |
| SCHEMBL13456236 | 0.75 | KDM1A (0.85) | KDM1ASLCO2B1SYNJ2DPP4POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023036973-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | MINASOLVE SAS (FR) | 2023-03-16 | — | — | WO | disclosed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3562472-B1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2021-05-19 | — | — | EP | disclosed |
| US-10981084-B2 | Use of coconut water as extraction solvent | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2021-04-20 | — | — | US | disclosed |
| US-20190336884-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2019-11-07 | — | — | US | disclosed |
| EP-3562472-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF Beauty Care Solutions France SAS (FR) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018122514-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2018-07-05 | — | — | WO | disclosed |
| EP-2858641-B1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORP (US) | 2017-09-06 | — | — | EP | disclosed |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2015-05-21 | — | — | US | disclosed |
| EP-2858641-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF Corporation (US) | 2015-04-15 | — | — | EP | disclosed |
| WO-2013184884-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORPORATION (US) | 2013-12-12 | — | — | WO | disclosed |
| US-7294330-B2 | prevent decomposition of steroid ester; inhibit odors | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-11-13 | — | — | US | disclosed |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | KDM1A 4518/4885SLCO2B1 4826/4885SYNJ2 3119/4885 |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | GUSB, PON1, IDUA | KDM1A 2894/4885SLCO2B1 597/4885SYNJ2 4276/4885 |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | ALG1, ALG8, CUTA | KDM1A 4518/4885SLCO2B1 4826/4885SYNJ2 3119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.